ERBB2 and breast cancer: The main prognostic biomarkers in early-stage breast cancer are tumor size, grade, lymph node status, number of positive lymph nodes, estrogen and progesterone receptor (ER, PgR) status and epidermal growth factor receptor 2 (HER2) status[7].